Home Uncertainty evaluation in clinical chemistry, immunoassay, hematology and coagulation analytes using only external quality assessment data
Article
Licensed
Unlicensed Requires Authentication

Uncertainty evaluation in clinical chemistry, immunoassay, hematology and coagulation analytes using only external quality assessment data

  • Yanyan Qin , Rui Zhou , Wei Wang , Hongyi Yin , Yanmin Yang , Yuhong Yue , Qing Tong , Lu Liu , Yali Jin , Yankun Shi , Shunli Zhang , Jianping Zhang , Rui Zhang , Chang Zuo , Tingting Jia , Ning Wang and Qingtao Wang EMAIL logo
Published/Copyright: April 23, 2018

Abstract

Background:

Measurement uncertainty (MU) is a parameter associated with the result of a measurement that characterizes its dispersion. We report results for estimating MU following the application of a top-down procedure using only proficiency test data to establish uncertainty levels for various analytes.

Methods:

Data were obtained from 142 laboratories participating in the Beijing Center for Clinical Laboratory (BCCL) proficiency testing/external quality assessment (PT/EQA) schemes. The 24-month study included six selected PT shipments to obtain estimates for 50th percentile (median) and 90th percentile MUs and to compare those estimates to usual analytic goals. The number of laboratory participants varied for each trial. The expanded uncertainty (U) was calculated using a cover factor of k=2 for a confidence interval of 95%. All reproducibility, method and laboratory biases came from the PT/EQA data.

Results:

The median U (k=2) ranged from 3.2% (plasma sodium, indirect ion selective electrode) to 32.8% (triglycerides, free glycerol blanking) for clinical chemistry analyte means from participants in the same method group. Immunoassay analyte median U results ranged from 11.3% (CA125 tumor marker, Roche) to 33.8% (prostate-specific antigen [PSA], Abbott). The range for median U was 3.5% (red blood cell [RBC], Abx) to 30.3% (fibrinogen [FBG], other) for hematology and coagulation analytes. The MUs for most analytes satisfied quality requirements.

Conclusions:

The use of PT/EQA data, when available, provides an effective means for estimating uncertainties associated with quantitative measurements. Thus, medical laboratories can calculate their own MUs. Proficiency testing organizers can provide participants with an additional MU estimate using only EQA data, which may be updated at the end of each survey.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by several funding programs: the National Natural Science Foundation of China (No. 81672074) for “The establishment of reference measurement system based on ID-LC/MS for glycated albumin and research about application in diagnosis of DM”; the National Clinical Key Specialty Construction Projects; the Beijing Capital Development Special Project for Health Research (2016-1-2031) for “The establishment and evaluation on the standardization method of point-of care HbA1c testing and on the method of HbA1c molecular typing by mass spectrometry at different level laboratories”; and the Beijing Municipal Administration of Hospitals for “Investigation on the quality control and the study on countermeasures of continuous improvement of municipal hospitals.”

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. JCGM. International vocabulary of metrology-basic and general concepts and associated terms (VIM), 200:2012.Search in Google Scholar

2. Dallas Jones GR. Measurement uncertainty for clinical laboratories – a revision of the concept. Clin Chem Lab Med 2016;54:1303–7.10.1515/cclm-2016-0311Search in Google Scholar PubMed

3. 15189: Medical laboratories-particular requirements for quality and competence. Geneva: International Organization for Standardization (ISO), 2012.Search in Google Scholar

4. Fuentes AX. Uncertainty of measurement in clinical microbiology. In: eJIFCC 2004;13. Available from: http://www.ifcc.org/ifccfiles/docs/130401006.pdf. Accessed: Dec 2016.Search in Google Scholar

5. International Laboratory Accreditation Cooperation (ILAC). ILAC G-17:2002. Available from: http://www.ilac.org. Accessed: Dec 2016.Search in Google Scholar

6. CLSI. Expression of measurement uncertainty in laboratory medicine; approved guideline. CLSI document EP29-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2012.Search in Google Scholar

7. Chen H, Zhang L, Bi X, Deng X. Two evaluation budgets for the measurement uncertainty of glucose in clinical chemistry. Korean J Lab Med 2011;31:167–71.10.3343/kjlm.2011.31.3.167Search in Google Scholar PubMed PubMed Central

8. Lee JH, Choi JH, Youn JS, Cha YJ, Song W, Park AJ. Comparison between bottom-up and top-down approaches in the estimation of measurement uncertainty. Clin Chem Lab Med 2015;53:1025–32.10.1515/cclm-2014-0801Search in Google Scholar PubMed

9. Magnusson B, Naykki T, Hovind H, Krysell M. Handbook for calculation of measurement uncertainty in environmental laboratories, NT TR 537 – Edition 3.1. Oslo, Norway: Nordic Innovation, 2012.Search in Google Scholar

10. CNAS-TRL-001: Evaluation and Expression of Measurement Uncertainty in the Medical Laboratory, China: China national accreditation service for conformity assessment (CNAS), 2012.Search in Google Scholar

11. Companyo R, Rubio R, Sahuquillo A, Boque R, Maroto A, Riu J. Uncertainty estimation in organic elemental analysis using information from proficiency tests. Anal Bioanal Chem 2008;392:1497–505.10.1007/s00216-008-2438-5Search in Google Scholar PubMed

12. Jarvis B, Corry JE, Hedges AJ. Estimates of measurement uncertainty from proficiency testing schemes, internal laboratory quality monitoring and during routine enforcement examination of foods. J Appl Microbiol 2007;103:462–7.10.1111/j.1365-2672.2006.03258.xSearch in Google Scholar PubMed

13. Rodomonte AL, Montinaro A, Bartolomei M. Uncertainty evaluation in the chloroquine phosphate potentiometric titration: application of three different approaches. J Pharm Biomed Anal 2006;42:56–63.10.1016/j.jpba.2006.05.026Search in Google Scholar PubMed

14. EUROLAB Technical Report N.1/2007. Measurement uncertainty revisited:alternative approaches to uncertainty evaluation, Technical Committee for Quality Assurance in Testing (TCQA), Paris, France, 2007.Search in Google Scholar

15. Meijer P, de Maat MP, Kluft C, Haverkate F, van Houwelingen HC. Long-term analytical performance of hemostasis field methods as assessed by evaluation of the results of an external quality assessment program for antithrombin. Clin Chem 2002;48:1011–5.10.1093/clinchem/48.7.1011Search in Google Scholar

16. ISO13528: Statistical methods for use in proficiency testing by interlaboratory comparisons. Geneva: International Organization for Standardization (ISO), 2005.Search in Google Scholar

17. ISO17043: Conformity assessment-general requirements for proficiency testing. Geneva: International Organization for Standardization (ISO), 2010.Search in Google Scholar

18. CLIA Proficiency Testing Criteria, Fed. Regist. 57(40) (February 28, 1992) 7002–7186 (See also www.westgard.com/clia.htm).Search in Google Scholar

19. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999;59:491–500.10.1080/00365519950185229Search in Google Scholar PubMed

20. Padoan A, Antonelli G, Aita A, Sciacovelli L, Plebani M. An approach for estimating measurement uncertainty in medical laboratories using data from long-term quality control and external quality assessment schemes. Clin Chem Lab Med 2017;55:1696–701.10.1515/cclm-2016-0896Search in Google Scholar PubMed

21. Matar G, Poggi B, Meley R, Bon C, Chardon L, Chikh K, et al. Uncertainty in measurement for 43 biochemistry, immunoassay, and hemostasis routine analytes evaluated by a method using only external quality assessment data. Clin Chem Lab Med 2015;53:1725–36.10.1515/cclm-2014-0942Search in Google Scholar PubMed

22. Zhou R, Qin Y, Yin H, Yang Y, Wang Q. Measurement uncertainty of gamma-glutamyltransferase (GGT) in human serum by four approaches using different quality assessment data. Clin Chem Lab Med 2018;56:242–8.10.1515/cclm-2017-0511Search in Google Scholar PubMed

Received: 2017-12-22
Accepted: 2018-03-13
Published Online: 2018-04-23
Published in Print: 2018-08-28

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. Clinical Chemistry and Laboratory Medicine continues to shine brightly in the constellation of laboratory medicine
  4. The Theranos saga and the consequences
  5. Innovative approaches in diabetes diagnosis and monitoring: less invasive, less expensive… but less, equally or more efficient?
  6. Reviews
  7. Exploring the microbiota to better understand gastrointestinal cancers physiology
  8. Linking type 2 diabetes and gynecological cancer: an introductory overview
  9. Mini Reviews
  10. MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma
  11. Salivary biomarkers and cardiovascular disease: a systematic review
  12. Opinion Paper
  13. The meteoric rise and dramatic fall of Theranos: lessons learned for the diagnostic industry
  14. General Clinical Chemistry and Laboratory Medicine
  15. Uncertainty evaluation in clinical chemistry, immunoassay, hematology and coagulation analytes using only external quality assessment data
  16. Measurement uncertainty and metrological traceability of whole blood cyclosporin A mass concentration results obtained by UHPLC-MS/MS
  17. Computer-assisted interventions in the clinical laboratory process improve the diagnosis and treatment of severe vitamin B12 deficiency
  18. Trueness, precision and stability of the LIAISON 1-84 parathyroid hormone (PTH) third-generation assay: comparison to existing intact PTH assays
  19. Fibroblast growth factor 23 and renal function among young and healthy individuals
  20. Optimizing charge state distribution is a prerequisite for accurate protein biomarker quantification with LC-MS/MS, as illustrated by hepcidin measurement
  21. Quantification of human complement C2 protein using an automated turbidimetric immunoassay
  22. EE score: an index for simple differentiation of homozygous hemoglobin E and hemoglobin E-β0-thalassemia
  23. Reference Values and Biological Variations
  24. Algorithm on age partitioning for estimation of reference intervals using clinical laboratory database exemplified with plasma creatinine
  25. A simple transformation independent method for outlier definition
  26. Cancer Diagnostics
  27. Quantification of vanillylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic acid in urine using a dilute-and-shoot and ultra-high pressure liquid chromatography tandem mass spectrometry method
  28. Cardiovascular Diseases
  29. Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease
  30. Diabetes
  31. Analysis of protein glycation in human fingernail clippings with near-infrared (NIR) spectroscopy as an alternative technique for the diagnosis of diabetes mellitus
  32. Letter to the Editor
  33. Preanalytical errors before and after implementation of an automatic blood tube labeling system in two outpatient phlebotomy centers
  34. Hemolysis interference studies: freeze method should be used in the preparation of hemolyzed samples
  35. The curious case of postprandial glucose less than fasting glucose: little things that matter much
  36. Finding best practice in internal quality control procedures using external quality assurance performance
  37. Evaluation of the analytical performance of a new ADVIA immunoassay using the Centaur XPT platform system for the measurement of cardiac troponin I
  38. Reference ranges of the Sebia free light chain ratio in patients with chronic kidney disease
  39. Antigen excess detection by automated assays for free light chains
  40. Multiple myeloma and macro creatine kinase type 1: the first case report
  41. Comparison of five cell-free DNA isolation methods to detect the EGFR T790M mutation in plasma samples of patients with lung cancer
  42. Can we use a point-of-care blood gas analyzer to measure the lactate concentration in cerebrospinal fluid of patients with suspected meningitis?
  43. Unstable haemoglobin variant Hb Leiden is detected on Sysmex XN-Series analysers
  44. Congress Abstracts
  45. 59th National Congress of the Hungarian Society of Laboratory Medicine
Downloaded on 12.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2017-1199/html
Scroll to top button